HepQuant DuO Test as Biomarker in Alcohol-related Liver Disease

This study aims to explore how well the liver recovers in individuals who have suffered liver damage related to alcohol use. It uses a special test called the HepQuant DuO to evaluate liver function and health. This blood-based test involves drinking a natural compound called cholate and then taking two blood samples at specific times. The participants in the study are individuals who have recently experienced alcohol-related liver injury. The goal is to gather information that can help better monitor and treat people with this condition, ultimately improving their care and outcomes. Participants in the study will visit an outpatient clinic four times over a year, specifically at 1, 3, 6, and 12 months. During each visit, they will take the HepQuant DuO test and undergo other routine medical tests. The study will also collect information about the participant's alcohol use, symptoms, and quality of life. One of the key measurements is the HepQuant Disease Severity Index (DSI), which ranges from 0, indicating no liver disease, to 50, indicating severe liver disease. This study seeks to understand how this index changes over time and how it relates to other standard tests for liver disease.